CVR: 39649772
Previous names: Trialink IVS, Connect2treat IVS
Connect2treat ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2018. The company is registered under the industry Computerprogrammering. The company was previously named Connect2treat IVS and Trialink IVS. The management consists of Tobias Julius Emil Horneman-Thielcke. The company is owned by Steiermark Group Holding ApS and Horneman-Thielcke Holding ApS. In 2025, the company reported a gross profit of DKK -4,875 and a net result of DKK -4,918 compared with DKK -4,453 the year before. Equity amounted to DKK -58,691.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med udvikling og drift af digitale platforme og tjenester samt enhver i forbindelse hermed stående virksomhed.
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorScreen owners and management against the Danish FSA's official PEP lists
Connect2treat ApS has published its annual report for 2025. Gross profit came to DKK -4,875, and the net result was DKK -4,918.
Connect2treat ApS has published its annual report for 2024. Gross profit came to DKK -4,426, and the net result was DKK -4,453.
Connect2treat ApS has published its annual report for 2023. Gross profit came to DKK -136,986, and the net result was DKK -47,186.
As of April 5, 2024, Tobias Julius Emil Horneman-Thielcke is registered as director of Connect2treat ApS.
As of April 5, 2024, Kristine Appel Uldall Pallesen has stepped down as adm. dir. of Connect2treat ApS.
Connect2treat ApS has published its annual report for 2022. Gross profit came to DKK -82,472, and the net result was DKK -108,623.
Connect2treat ApS has published its annual report for 2021. Gross profit came to DKK 128,916, and the net result was DKK 81,262.
Connect2treat ApS has published its annual report for 2020. Gross profit came to DKK 64,289, and the net result was DKK 38,063.
Connect2treat ApS has published its annual report for 2019. Gross profit came to DKK -41,619, and the net result was DKK -52,846.
As of December 2, 2019, Kristine Appel Uldall Pallesen is registered as adm. dir. of Connect2treat ApS.
As of December 2, 2019, Katrine Lund Horneman-Thielcke has stepped down as director of Connect2treat ApS.
As of October 7, 2019, Katrine Lund Horneman-Thielcke is registered as director of Connect2treat ApS.
As of October 7, 2019, Tobias Julius Emil Horneman-Thielcke has stepped down as director of Connect2treat ApS.
On September 20, 2019, the company changed its name from Connect2treat IVS to Connect2treat ApS.
Connect2treat ApS has published its interim report for the period June 18, 2018 – December 31, 2018.
On April 26, 2019, the company changed its name from Trialink IVS to Connect2treat IVS.
As of October 16, 2018, Tobias Julius Emil Horneman-Thielcke is registered as director of Connect2treat ApS.
As of October 16, 2018, Jesper Krogh Støttrup has stepped down as director of Connect2treat ApS.
As of October 16, 2018, Steiermark Group Holding ApS is registered as an owner of Connect2treat ApS with an ownership share of 5%.
As of October 16, 2018, Horneman-Thielcke Holding ApS is registered as an owner of Connect2treat ApS with an ownership share of 90%.
As of June 18, 2018, Jesper Krogh Støttrup is registered as director of Connect2treat ApS.
Connect2treat ApS was founded on June 18, 2018.
Companies in the same industry and area
CVR 46319095
CVR 14940391
CVR 42721204
CVR 46257464
CVR 29772185
companydata.dk